Researchers analyzed 10 states that had such a requirement.
Here are four things to know:
1. States had a decline in the number of Medicare beneficiaries who received a more than seven-month opioid supply in a six-month period when imposing the database referral requirement.
2. The number of Medicare opioid users who obtained prescriptions from five or more physicians decreased by 8 percent.
3. Medicare opioid users who received prescriptions from five or more pharmacies also fell by more than 15 percent.
4. The requirement had the greatest impact on low-income disabled users and those Medicare patients who shopped around for opioid prescriptions. These groups typically have the highest misuse and abuse opioid rates.
More articles on quality and infection control:
Nearly 22k US malaria-related hospitalizations reported in 14 years: 7 takeaways
AAFP submits physician-focused alternative payment model: 6 things to know
3 strategies to improve patients’ opioid storage, disposal practices
